Medical Journal Abstracts Below are a sampling of the extensive research performed on 12-lead CCG FDA-cleared products
Abstract 1
Hospital
ASSN Private Hospital, University of Modena and Reggio, Cotignolo, Italy
Author
G.Norea, F. Ouedia, M.D.
Journal of Arteriosclerosis Vol. 24 No. 2/1999, pp 88-84
Title
Cardiac Ultra-Phase Information Diagnosis (CUPID): New Method and Instrumentation, New Possibilities for Early Diagnosis of Coronary Artery Disease in the Elderly
Results
Randomized, double-blind study of 170 patients with CAD and other cardiac pathologies shows 100% sensitivity and 98% specificity.
Abstract 2
Hospital
New York Hospital, USA and four other major hospitals
Author
Bisa Schramm, M.D.
Annual Scientific Meeting at Prevention ‘97
Title
Clinical Effectiveness of EKG Ultra-Phase Diagnosis in Early Detection of Heart Dysfunction
Results
Double-blind test of 258 patients and 121 normals at five major hospitals. Up to 95% accuracy in qualitative diagnosis and up to 94% accuracy in differential diagnosis.
Abstract 3
Hospital
Institute of Heart and Great Vessels ”Attillo Reale,” University, Rome, Italy
Frequency-Domain Analysis of Left Ventricular Hypertrophy by Crebro-Cardiogram (CCG) is an Accurate Tool
Results
With an overall sample study of 22 patients (67% men, mean age 57 ±15 years), the predictive accuracy on left ventricular hypertrophy is 86%.
Abstract 4
Hospital
Riverside Methodist Hospital, Ohio, USA
Author
John T. Huston, M.D.
Title
Clinical Utility of EMP for Early Detection of Heart Diseases
Results
54 patients – Qualitative diagnostic accuracy is 92%; differential diagnostic accuracy is 89%.
Abstract 5
Hospital
Cardiovasculaire, Centre Hospitalier Universitaire, Universite de Paris, France, and;
Division of Cardiovascular Diseases, University of Alabama, Birmingham, USA.
Author
Frederic Fillette, M.D.
Title
Improved ECG Interpretation Using the Early ECG Multiphase Diagnostic System for Angina and Interpretation
Results
Initial phase (29 subjects) –
The results for Angina patients is:
92.8% sensitivity
93.3% specificity
92.2% PPV, and
93.3% NPV
The results for Myocardial Infarction patients is:
91.6% sensitivity
89.5% specificity
84.6% PPV, and
89.5% NPV
Second phase (59 patients) – in this subsequent testing, the CAD diagnostic accuracy is 94%.
